Macarius Donneyong, PhD, MPH
Professional Interests
Dr. Macarius Donneyong is an Assistant Professor with joint faculty appointments in the Colleges of Pharmacy and Public Health at The Ohio State University. He teaches courses on drug literature evaluation in the PharmD program and a graduate course on healthcare data analytics through the College of Public Health.
Research Interests
Dr. Donneyong’s research goal is to help improve the health of racial/ethnic minorities by generating information to improve adherence, safety and effectiveness of prescribed medication. His major research interest in this area include:
- The direct and indirect role of social determinants of health on medication utilization, adherence and effectiveness.
- The effect of patient-provider relationships on medication treatment outcomes.
- How to prevent harmful effects of drug-drug interactions: polypharmacy increases exposure to drug-drug interaction and is more prevalent among racial/ethnic minorities because of higher prevalence of multiple chronic conditions.
Learn more about Dr. Donneyong's research interests.
Courses
The Ohio State University, College of Public Health
2018 – Present: PUBHHMP 6625; Leveraging Healthcare Data for Practice and Policy Change, Principal instructor
The Ohio State University, College of Pharmacy
2017 – Present: PHR 6303; Concepts in Patient Care, Co-instructor
Education
- 2013, PhD, University of Louisville
- 2009, MPH, Missouri State University
- 2005, BSc, University of Ghana
Journal Articles
Chang TJ, Bridges JFP, Bynum M, Jackson JW, Joseph JJ, Fischer MA, Lu B, Donneyong MM. Association Between Patient-Clinician Relationships and Adherence to Antihypertensive Medications Among Black Adults: An Observational Study Design. J Am Heart Assoc. 2021 Jul 20;10(14):e019943. doi: 10.1161/JAHA.120.019943. Epub 2021 Jul 9. PMID: 34238022.
Jin Q, Hart PA, Shi N, Joseph JJ, Donneyong M, Conwell DL, Clinton SK, Cruz- Monserrate Z, Brasky TM, Tinker LF, Liu S, Shadyab AH, Thomson CA, Qi L, Rohan T, Tabung FK. Dietary Patterns of Insulinemia, Inflammation and Glycemia, and Pancreatic Cancer Risk: Findings from the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1229-1240. doi: 10.1158/1055-9965.EPI-20-1478. Epub 2021 Apr 7. PMID: 33827986; PMCID: PMC8172436.
Donneyong MM, Chang TJ, Pottegård A, Ankrah D, Asenso-Boadi F, Addo-Cobbiah V, Dsane-Selby L, Hallas J. Prevalence and quality of antihypertensive therapy among hypertension patients enrolled in the Ghana National Health Insurance Scheme. Pharmacoepidemiol Drug Saf. 2021 May 26. doi: 10.1002/pds.5298. Epub ahead of print. PMID: 34038608.
Jin Q, Shi N, Aroke D, Lee DH, Joseph JJ, Donneyong M, Conwell DL, Hart PA, Zhang X, Clinton SK, Cruz-Monserrate Z, Brasky TM, Jackson R, Tinker LF, Liu S, Phillips LS, Shadyab AH, Nassir R, Bao W, Tabung FK. Insulinemic and Inflammatory Dietary Patterns Show Enhanced Predictive Potential for Type 2 Diabetes Risk in Postmenopausal Women. Diabetes Care. 2021 Mar;44(3):707-714. doi: 10.2337/dc20-2216. Epub 2021 Jan 8. PMID: 33419931; PMCID: PMC7896263.
Salas M, Lopes LC, Godman B, Truter I, Hartzema AG, Wettermark B, Fadare J, Burger JR, Appenteng K, Donneyong M, Arias A, Ankrah D, Ogunleye OO, Lubbe M, Horne L, Bernet J, Gómez-Galicia DL, Del Carmen Garcia Estrada M, Oluka MN, Massele A, Alesso L, Herrera Comoglio R, da Costa Lima E, Vilaseca C, Bergman U. Challenges facing drug utilization research in the Latin American region. Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1353-1363. doi: 10.1002/pds.4989. Epub 2020 May 17. PMID: 32419226.
Donneyong MM, Chang TJ, Jackson JW, Langston MA, Juarez PD, Sealy-Jefferson S, Lu B, Im W, Valdez RB, Way BM, Colen C, Fischer MA, Salsberry P, Bridges JFP, Hood DB. Structural and Social Determinants of Health Factors Associated with County-Level Variation in Non-Adherence to Antihypertensive Medication Treatment. Int J Environ Res Public Health. 2020 Sep 14;17(18):6684. doi: 10.3390/ijerph17186684. PMID: 32937852; PMCID: PMC7557537.
Donneyong MM, Chang TJ, Roth JA, Guilds M, Ankrah D, Najafzadeh M, Xu WY, Chlebowski RT, Margolis K, Manson JE. The Women's Health Initiative Estrogen- alone Trial had differential disease and medical expenditure consequences across age groups. Menopause. 2020 Jun;27(6):632-639. doi: 10.1097/GME.0000000000001517. PMID: 32132440; PMCID: PMC7255959.
Juarez PD, Tabatabai M, Valdez RB, Hood DB, Im W, Mouton C, Colen C, Al- Hamdan MZ, Matthews-Juarez P, Lichtveld MY, Sarpong D, Ramesh A, Langston MA, Rogers GL, Phillips CA, Reichard JF, Donneyong MM, Blot W. The Effects of Social, Personal, and Behavioral Risk Factors and PM<sub>2.5</sub> on Cardio- Metabolic Disparities in a Cohort of Community Health Center Patients. Int J Environ Res Public Health. 2020 May 19;17(10):3561. doi: 10.3390/ijerph17103561. PMID: 32438697; PMCID: PMC7277630.
Vyas CM, Donneyong M, Mischoulon D, Chang G, Gibson H, Cook NR, Manson JE, Reynolds CF 3rd, Okereke OI. Association of Race and Ethnicity With Late-Life Depression Severity, Symptom Burden, and Care. JAMA Netw Open. 2020 Mar 2;3(3):e201606. doi: 10.1001/jamanetworkopen.2020.1606. PMID: 32215634; PMCID: PMC7325738.
Donneyong M, Reynolds C, Mischoulon D, Chang G, Luttmann-Gibson H, Bubes V, Guilds M, Manson J, Okereke O. Protocol for studying racial/ethnic disparities in depression care using joint information from participant surveys and administrative claims databases: an observational cohort study. BMJ Open. 2020 Jan 7;10(1):e033173. doi: 10.1136/bmjopen-2019-033173. PMID: 31915172; PMCID: PMC6955513.